AAAAAA
Results:
1-7
|
Results: 7
Authors:
PAIRET M
DIEDEREN W
GUTH B
KANAI K
MAUZ A
PIEPER M
VANRYN J
SCHIEROK H
WALLAND A
WINQUIST R
Citation: M. Pairet et al., GENERAL PHARMACOLOGY STUDIES IN THE PHARMACEUTICAL-INDUSTRY - EXAMPLEOF A BASIC PROGRAM, Drug development research, 42(2), 1997, pp. 57-62
Authors:
NARJES H
MULLER TH
WEISENBERGER H
GUTH B
BRICKL R
Citation: H. Narjes et al., INHIBITION OF PLATELET-AGGREGATION AS A SURROGATE MARKER, Journal of clinical pharmacology, 37(1), 1997, pp. 59-64
Authors:
NARJES HH
WEISENBERGER H
GUTH B
MULLER TH
DEICHSEL G
KRAUSE J
SU CAPF
Citation: Hh. Narjes et al., SAFETY, PHARMACOKINETICS AND DYNAMICS OF THE ORAL GPIIB IIIA INHIBITOR LEFRADAFIBAN IN HEALTHY-VOLUNTEERS/, Circulation, 96(8), 1997, pp. 4042-4042
Authors:
GUTH B
HUDELSON J
HIGBIE J
SOLOMON B
POLLEY S
THOMAS S
GENTRY WL
Citation: B. Guth et al., PREDICTIVE VALUE OF HCG LEVEL 14 DAYS AFTER EMBRYO-TRANSFER, Journal of assisted reproduction and genetics, 12(1), 1995, pp. 13-14
Authors:
MULLER TH
WEISENBERGER H
BRICKL R
KIRCHNER M
NARJES H
HIMMELSBACH F
GUTH B
KRAUSE J
Citation: Th. Muller et al., PHARMACODYNAMICS AND PHARMACOKINETICS OF BIBU-52, A PLATELET GLYCOPROTEIN (GP) IIB IIIA ANTAGONIST, AND ITS ORALLY-ACTIVE PRODRUG BIBU-104 IN MAN/, Thrombosis and haemostasis, 73(6), 1995, pp. 1445-1445
Authors:
HIMMELSBACH F
AUSTEL V
GUTH B
LINZ G
MULLER TH
PIEPER H
SEEWALDTBECKER E
WEISENBERGER H
Citation: F. Himmelsbach et al., DESIGN OF HIGHLY POTENT NONPEPTIDIC FIBRINOGEN RECEPTOR ANTAGONISTS, European journal of medicinal chemistry, 30, 1995, pp. 243-254
Authors:
GUTH B
MULLANE K
Citation: B. Guth et K. Mullane, COMPARISON OF EXERCISE AND CATECHOLAMINE STRESS AGENTS IN PRODUCING MYOCARDIAL-ISCHEMIA, Journal of the American College of Cardiology, 1994, pp. 10000015-10000015
Risultati:
1-7
|